• Macrophage EV miR-660 Drives Breast Cancer Metastasis via KL

  2026-07-01

  This study uncovers how tumor-associated macrophage-derived extracellular vesicles (EVs) deliver microRNA-660 to breast cancer cells, downregulating KLHL21 and activating the NF-κB pathway to promote metastasis. These findings clarify a novel mechanistic link in the tumor microenvironment, informing future strategies for targeting metastatic breast cancer.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Study Advanc

  2026-07-01

  This review highlights the theranostic potential of CXCR4-targeted imaging ligands in lymphoma, detailing how molecular imaging and precision therapeutic approaches leverage CXCR4's role in tumor progression and therapy resistance. The findings emphasize the integration of diagnostic and targeted treatment strategies, with implications for improving lymphoma management and prognosis.

• Caffeine (1,3,7-trimethylpurine-2,6-dione) in Cancer & Metab

  2026-06-30

  Caffeine’s dual role as an adenosine receptor antagonist and metabolic modulator unlocks advanced research workflows in cancer inhibition and energy regulation. Discover practical protocols, troubleshooting insights, and cross-domain applications that set APExBIO’s Caffeine apart for high-impact bench research.

• LMO2-LDB1 Complex Drives AML Progression: Mechanisms and Imp

  2026-06-30

  The referenced study elucidates how the LMO2 transcription factor promotes acute myeloid leukemia (AML) progression through direct interaction with the co-regulator LDB1. The findings highlight a critical protein complex that regulates leukemia cell survival and proliferation, suggesting new molecular targets for AML intervention.

• Optimizing Neuroinflammation Assays with MOG (35-55) Peptide

  2026-06-29

  This article delivers an evidence-driven, scenario-based guide to using MOG (35-55) Peptide (SKU A8306) in cell viability, proliferation, and autoimmune encephalomyelitis research. Drawing on peer-reviewed findings and real laboratory challenges, it demonstrates how A8306 ensures data reliability, protocol consistency, and robust modeling for multiple sclerosis studies.

• Mitoxantrone HCl: Advanced DNA Topoisomerase II Inhibitor Wo

  2026-06-29

  Mitoxantrone HCl stands out as a dual-action DNA topoisomerase II inhibitor and nuclear receptor disruptor, enabling novel approaches in apoptosis research and resistance modeling. This article provides actionable protocols, troubleshooting strategies, and a translation of cutting-edge mechanistic findings into practical lab applications.

• TUNEL Apoptosis Detection Kit: Applied Workflows and Trouble

  2026-06-28

  Unlock precise, reproducible apoptosis quantification across tissue and cell models with the TUNEL Apoptosis Detection Kit (DAB). This article delivers actionable protocol guidance, advanced use-cases, and troubleshooting strategies, all anchored in recent neurovascular and translational research.

• Carfilzomib (PR-171): Precision Proteasome Inhibition Workfl

  2026-06-27

  Carfilzomib (PR-171) enables targeted, irreversible proteasome inhibition in cancer research, offering reproducible apoptosis induction and translational flexibility. This guide delivers actionable protocols, troubleshooting strategies, and workflow integration tips for maximizing the value of Carfilzomib in preclinical and advanced oncology studies.

• Taltirelin Acetate: Protocol Innovations for Neuroprotection

  2026-06-26

  Taltirelin acetate is transforming preclinical research with its dual role in neuroprotection and antipruritic modeling. New reference studies offer actionable dosing and workflow optimizations, directly elevating assay reliability and translational potential.

• Carfilzomib (PR-171): Unlocking ER Stress-Induced Cell Death

  2026-06-26

  Explore how Carfilzomib (PR-171) leverages proteasome inhibition to amplify ER stress and multi-modal cell death in cancer research. This article delivers a unique, mechanism-driven perspective grounded in recent translational findings.

• Bromodomain Inhibitor, (+)-JQ1: Mechanism, Evidence & Limits

  2026-06-25

  Bromodomain Inhibitor, (+)-JQ1 is a potent, selective BET bromodomain inhibitor with nanomolar affinity, disrupting BRD4- and BRDT-mediated chromatin regulation. It induces caspase 3/7-mediated apoptosis in cancer models and acts as a non-hormonal male contraceptive. Its efficacy and mechanistic specificity are supported by peer-reviewed studies and product validation.

• WP1066, JAK2/STAT3 Inhibitor: Precision Modulation in Tumor

  2026-06-25

  Explore how WP1066, a potent JAK2/STAT3 inhibitor, advances cancer and immunometabolic research by precisely targeting oncogenic and regenerative pathways. This article uniquely connects mechanistic insights with practical workflows for tumor biology and macrophage modulation.

• MLN4924 (SKU B1036): Best Practices for Reliable Neddylation

  2026-06-24

  This article provides scenario-driven, evidence-based guidance for using MLN4924 (SKU B1036) in cancer biology research, focusing on real laboratory challenges and practical solutions. By integrating quantitative data and validated protocols, it empowers bench scientists and lab technicians to optimize cell viability, proliferation, and cytotoxicity assays with high confidence in reproducibility and selectivity.

• Arachidonic Acid Supplementation Rapidly Boosts Humoral Immu

  2026-06-23

  The reference study demonstrates that dietary arachidonic acid (ARA) supplementation significantly accelerates and amplifies vaccine-induced humoral immunity in both mice and humans. By elucidating the metabolic and molecular mechanisms in lymphoid tissues, the work points to promising nutritional strategies for enhancing vaccine efficacy and immune protection.

• Peptidisc-Driven Nanobody Multimerization: Expanding Protein

  2026-06-23

  Chen and Duong van Hoa introduce a peptidisc-assisted approach for assembling nanobodies into multimeric and multispecific protein complexes. This strategy leverages hydrophobic clustering to enhance affinity and functional diversity, offering a robust alternative to traditional multimerization methods with important implications for biochemical research and protein labeling workflows.

483 records 8/33 page Previous Next First page 上5页 678910 下5页 Last page